20th September 2018

Blanc climbs Blanc

Blanc climbs Blanc

We caught up with CEO Peter Blanc to talk to him about his three day experience, trekking the Mont Blanc Massif as part of The Insurance United against Dementia (IUAD) campaign.


Q. Can you tell everyone a bit more about the IUAD.

A. “The IUAD has become the chosen charity of the insurance industry and it’s amazing how getting everyone focused on one cause has created such momentum. There will be an Insurance Day of Giving coming up and if everyone employed in Insurance gave say £10 the sum raised would be breath-taking. Dementia affects nearly everyone at some point - so it’s a really worthwhile cause. Alzheimer’s Society are actively working on finding treatments and they’re developing a test that will screen people for dementia and they’re confident that within ten years there will be a real breakthrough.


Q. What did you find the hardest in the 3 days of the trek?

A. The first morning of the trek was really challenging - the initial ascent was some 800m and really steep; I don’t think any of us expected it to be as difficult! After four hours of climbing the first packed lunch on the mountain tasted amazing.


Q. What was your favourite spot of the trek, any particular landmark?

A. Every time we went round a corner or over a peak the views were stunning.


Q. What did you most enjoy about the 3 days?

A. On the last day we had a very long slippery descent - one of the team put an 80’s playlist together and we had a good singalong all the way down which really helped the sore knees.


Q. Is the trek going to be an annual event for the IUAD and how can others get involved if so?

A. We’re hoping to put together other challenges for next year so I’ll keep you posted!


The trek team have raised so far £95,823 for Alzheimer’s Society and there is still time to donate to this fantastic course to help create a world without Dementia. Peter would like to personally thank everybody for their support and sponsorships which is greatly appreciated by all at Alzheimer’s.